Literature DB >> 12673461

Dangerous nutrition? Calcium, vitamin D, and shark cartilage nutritional supplements and cancer-related hypercalcemia.

Ruth Lagman1, Declan Walsh.   

Abstract

The use of nutritional supplements in the general population and in cancer patients has become very popular. These supplements are not perceived as medications and are presumed to be safe by cancer patients, who may however be at risk for hypercalcemia. We note that many of our patients who have developed symptomatic hypercalcemia were taking vitamin D, calcium, or shark cartilage supplements. We report eight cases of hypercalcemia in cancer patients seen at the Cleveland Clinic Foundation in whom these nutritional supplements may have contributed to the prevalence or severity of hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673461     DOI: 10.1007/s00520-002-0428-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  8 in total

Review 1.  Evaluation of botanicals and dietary supplements therapy in cancer patients.

Authors:  V L Go; D A Wong; M S Resnick; D Heber
Journal:  J Nutr       Date:  2001-01       Impact factor: 4.798

Review 2.  The prevalence of complementary/alternative medicine in cancer: a systematic review.

Authors:  E Ernst; B R Cassileth
Journal:  Cancer       Date:  1998-08-15       Impact factor: 6.860

3.  Evaluation and treatment of hypercalcemia.

Authors:  G R Mundy
Journal:  Hosp Pract (Off Ed)       Date:  1994-06-15

Review 4.  The role of cytokines in cancer cachexia.

Authors:  J M Argilés; F J López-Soriano
Journal:  Med Res Rev       Date:  1999-05       Impact factor: 12.944

5.  Altered renal calcium handling in hypercalcemia of malignancy.

Authors:  K R Tuttle; R T Kunau; N Loveridge; G R Mundy
Journal:  J Am Soc Nephrol       Date:  1991-08       Impact factor: 10.121

6.  The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost.

Authors:  M Miller; M J Boyer; P N Butow; M Gattellari; S M Dunn; A Childs
Journal:  Support Care Cancer       Date:  1998-07       Impact factor: 3.603

7.  Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy.

Authors:  W J Burtis; T Wu; C Bunch; J J Wysolmerski; K L Insogna; E C Weir; A E Broadus; A F Stewart
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

Review 8.  Vitamins for chronic disease prevention in adults: scientific review.

Authors:  Kathleen M Fairfield; Robert H Fletcher
Journal:  JAMA       Date:  2002-06-19       Impact factor: 56.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.